STRATA Skin Sciences (SSKN) Competitors $3.00 -0.04 (-1.32%) (As of 05:12 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SSKN vs. ICAD, NTRB, LUCD, BLAC, CLGN, COCH, MDAI, SURG, XAIR, and NXGLShould you be buying STRATA Skin Sciences stock or one of its competitors? The main competitors of STRATA Skin Sciences include iCAD (ICAD), Nutriband (NTRB), Lucid Diagnostics (LUCD), Bellevue Life Sciences Acquisition (BLAC), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Spectral AI (MDAI), SurgePays (SURG), Beyond Air (XAIR), and NEXGEL (NXGL). These companies are all part of the "medical equipment" industry. STRATA Skin Sciences vs. iCAD Nutriband Lucid Diagnostics Bellevue Life Sciences Acquisition CollPlant Biotechnologies Envoy Medical Spectral AI SurgePays Beyond Air NEXGEL iCAD (NASDAQ:ICAD) and STRATA Skin Sciences (NASDAQ:SSKN) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, valuation, earnings, community ranking, profitability, dividends, analyst recommendations, institutional ownership and media sentiment. Do insiders and institutionals believe in ICAD or SSKN? 24.6% of iCAD shares are held by institutional investors. Comparatively, 32.4% of STRATA Skin Sciences shares are held by institutional investors. 10.3% of iCAD shares are held by insiders. Comparatively, 39.0% of STRATA Skin Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media favor ICAD or SSKN? In the previous week, iCAD and iCAD both had 1 articles in the media. STRATA Skin Sciences' average media sentiment score of 1.34 beat iCAD's score of 0.41 indicating that STRATA Skin Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iCAD 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral STRATA Skin Sciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation and earnings, ICAD or SSKN? iCAD has higher earnings, but lower revenue than STRATA Skin Sciences. iCAD is trading at a lower price-to-earnings ratio than STRATA Skin Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioiCAD$18.94M2.56-$4.85M-$0.13-14.08STRATA Skin Sciences$32.68M0.39-$10.83M-$2.66-1.16 Which has more risk & volatility, ICAD or SSKN? iCAD has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500. Comparatively, STRATA Skin Sciences has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Is ICAD or SSKN more profitable? iCAD has a net margin of -17.81% compared to STRATA Skin Sciences' net margin of -28.72%. iCAD's return on equity of -15.65% beat STRATA Skin Sciences' return on equity.Company Net Margins Return on Equity Return on Assets iCAD-17.81% -15.65% -12.52% STRATA Skin Sciences -28.72%-69.33%-17.55% Does the MarketBeat Community favor ICAD or SSKN? iCAD received 5 more outperform votes than STRATA Skin Sciences when rated by MarketBeat users. However, 63.90% of users gave STRATA Skin Sciences an outperform vote while only 62.13% of users gave iCAD an outperform vote. CompanyUnderperformOutperformiCADOutperform Votes22862.13% Underperform Votes13937.87% STRATA Skin SciencesOutperform Votes22363.90% Underperform Votes12636.10% SummaryiCAD beats STRATA Skin Sciences on 8 of the 14 factors compared between the two stocks. Ad Paradigm PressMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. Get STRATA Skin Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SSKN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SSKN vs. The Competition Export to ExcelMetricSTRATA Skin SciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$12.51M$4.29B$5.04B$8.94BDividend YieldN/A44.87%4.83%4.06%P/E Ratio-1.1325.08133.9116.95Price / Sales0.3844.011,148.46127.83Price / CashN/A44.2040.5637.95Price / Book0.827.054.754.71Net Income-$10.83M$13.83M$118.62M$225.30M7 Day Performance-0.99%-5.37%12.00%-3.74%1 Month PerformanceN/A0.28%12.07%4.48%1 Year Performance-46.43%43.68%31.52%18.72% STRATA Skin Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SSKNSTRATA Skin Sciences2.2987 of 5 stars$3.00-1.3%N/A-50.0%$12.51M$32.68M-1.13120Positive NewsGap UpICADiCAD0.3262 of 5 stars$1.85-5.1%N/A+21.8%$49.10M$18.94M-15.0067NTRBNutriband0.48 of 5 stars$4.39+6.0%N/A+75.7%$48.76M$2.02M-5.8310Positive NewsGap UpLUCDLucid Diagnostics2.524 of 5 stars$0.81+3.2%$3.63+347.3%-38.4%$48.10M$4.19M-0.6970High Trading VolumeBLACBellevue Life Sciences AcquisitionN/A$11.26-0.5%N/A+7.5%$45.49MN/A0.00N/ACLGNCollPlant Biotechnologies3.0853 of 5 stars$3.67-0.5%$12.50+240.6%-30.1%$42.02M$10.96M-2.4070Positive NewsCOCHEnvoy Medical3.389 of 5 stars$1.89-3.6%$8.00+323.3%-22.4%$38.27M$320,000.000.0034News CoveragePositive NewsGap DownMDAISpectral AI2.7044 of 5 stars$2.05+13.9%$4.50+119.5%-29.9%$38.11M$18.06M-3.1178SURGSurgePays2.8836 of 5 stars$1.74-2.2%$8.50+388.5%-66.5%$35.08M$137.14M-1.5822Analyst ForecastXAIRBeyond Air4.1918 of 5 stars$0.48+3.2%$3.67+663.9%-71.0%$34.65M$1.16M-0.3370Gap UpNXGLNEXGEL1.4158 of 5 stars$4.97+5.5%N/A+113.6%$33.75M$6.73M-8.1210Positive NewsHigh Trading Volume Related Companies and Tools Related Companies iCAD Alternatives Nutriband Alternatives Lucid Diagnostics Alternatives Bellevue Life Sciences Acquisition Alternatives CollPlant Biotechnologies Alternatives Envoy Medical Alternatives Spectral AI Alternatives SurgePays Alternatives Beyond Air Alternatives NEXGEL Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SSKN) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored“The Last Retirement Stock You’ll Ever Need”We've just released a critical trade alert about a groundbreaking AI investment opportunity. So, I wanted t...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share STRATA Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
